Multi-state cannabis company, Verano Holdings Corp., started a fundraising campaign with their BITS™ edibles product for Breast Cancer Awareness Month with a portion of the proceeds going to the Lynn Sage Breast Cancer Foundation.
As the month of October comes around, fall colors aren’t the only thing you’ll see. Often, you’ll encounter the color “pink” because October is Breast Cancer Awareness Month. To help raise awareness for breast cancer, multi-state cannabis company, Verano Holdings Corp. (Verano), started a fundraising campaign called “Save the Bits”. According to a recent press release (1), Verano will be donating a portion of their proceeds from the sale of their BITS™ edibles product which is offered at hundreds of cannabis dispensaries found in eight states to the Lynn Sage Breast Cancer Foundation.
The fundraiser will start on October 1, 2024, and run through the month of October. Inside the packages of their BITS™ edibles product will be a “Save the Bits” sticker to help support the initiative of eradicating breast cancer, as well as a QR code which will bring consumers to a location where they can learn more information and “education on the campaign’s mission” (1). The “Save the Bits” campaign, “…will be supported with in-store and digital education elements to provide further awareness of this important cause across 225 dispensaries in eight states – comprised of 134 of the Company’s Zen Leaf and MÜV dispensaries and 91 participating third-party dispensaries,” (1). According to the press release (1), at least 40 third-party cannabis companies will participate in this initiative in various states such as, New Jersey, Pennsylvania, Arizona, Maryland, Illinois, Massachusetts, Florida, and Nevada, with digital and in-store activations. The BITS™ edibles are low-dose and high-functioning and offered in five flavor varieties that contain 5 mg of tetrahydrocannabinol (THC) and other adaptogens/cannabinoids (1).
Laura Sage, Executive Director of the Lynn Sage Breast Cancer Foundation stated (1), “The Lynn Sage Breast Cancer Foundation is honored to partner with BITS™ to fund cutting-edge breast cancer trials that are accessible to a diverse group of patients. We are grateful for their generosity and continued support of the 1:8 women diagnosed with breast cancer.”
“We are thrilled to launch the Save the Bits campaign in partnership with our peers in the cannabis community to benefit the Lynn Sage Breast Cancer Foundation,” George Archos, Verano Founder and Chief Executive Officer commented (1). “Save the Bits is a powerful demonstration of the cannabis industry’s ability to deliver positive benefits for communities and important causes across the country, and we’re proud to stand together and support the fight against Breast Cancer throughout October.”
To learn more about the “Save the Bits” Breast Cancer Fundraiser, visit (1,2): https://pages.bitsedibles.com/savethebits. For more information regarding the Lynn Sage Breast Cancer Foundation, visit (1,3): https://lynnsage.org/.
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.